CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in COGT — Cogent Biosciences, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in COGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$56,087,910
+$8,270,937 QoQ
Shares Held
1,449,300
+16.7% QoQ
Ownership
0.835%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 321 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. COGT ranks #34 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in COGT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,087,910 | 1,449,300 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $47,816,973 | 1,242,322 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $45,493,270 | 1,280,779 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $17,097,662 | 1,190,645 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,368,566 | 886,987 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,949,507 | 826,295 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $6,498,609 | 833,155 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $8,918,564 | 825,793 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,788,855 | 686,697 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,159,921 | 619,036 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,563,450 | 606,029 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,776,797 | 592,492 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,305,567 | 194,727 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,892,922 | 175,433 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,980,285 | 171,305 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,512,214 | 168,379 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,021,018 | 113,195 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $732,349 | 97,777 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $838,926 | 97,777 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $789,623 | 93,891 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $761,942 | 93,951 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||